% Expired Patents = 75.0

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 9

Loading Chart...

3 inventors (with patents filed for the assignee):

Michael Brines (8 out of 22 patents)

Anthony Cerami (8 out of 167 patents)

Thomas Coleman (4 out of 6 patents)

8 patents: Sort by Forward Citations

1. 10864253 - Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage (2020-12-15),

2. 10100096 - Tissue protective peptides and uses thereof (2018-10-16),

3. 9580465 - Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage (2017-02-28),

4. 9340598 - Tissue protective peptides and uses thereof (2016-05-17),

5. 8853358 - Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage (2014-10-07),

6. 8716245 - Tissue protective peptides and uses thereof (2014-05-06),

7. 8673861 - Tissue protective peptides and uses thereof (2014-03-18),

8. 8071554 - Tissue protective peptides and uses thereof (2011-12-06),

Company Overview

Araim Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on developing innovative therapies for a range of diseases. With a strong emphasis on research and development, Araim is dedicated to improving patient outcomes and making a meaningful impact in the healthcare industry. The company's cutting-edge approach to drug discovery and development sets it apart as a pioneer in the field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#21 in Tarrytown, NY

#2,107 in New York

#35,941 in US

Tarrytown, NY, United States of America

Araim Pharmaceuticals, Inc.

Forward Citations = 9

3 inventors:

Michael Brines (8 out of 22 patents)

Anthony Cerami (8 out of 167 patents)

Thomas Coleman (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Araim Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/araim-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]